Skip to content

Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)

Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)on Behalf of Chinese Ostomy Collaboration Group (COCG-02)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06194708
Enrollment
235
Registered
2024-01-08
Start date
2023-05-15
Completion date
2027-01-01
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

The goal of this observational study is to learn about in mid-low rectal patients who received temporary ostomies after surgery of the primary tumors. The main questions it aims to answer are: * To explore the proportion of temporary stomas that cannot be reversed after radical surgery for mid-low rectal cancer and their main causes. * To use the basic information we collected from patients before and during surgery to develop an individualized model for predicting the time of stoma reversal and explore the risk factors affecting stoma reversal.

Interventions

None listed

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Pathologically confirmed as rectal adenocarcinoma; * The tumor is located within 12cm from the anal verge; * Primary tumor is radically resected; * The patient received a temporary ostomy during the in-hospital visit of the resection of the primary tumor.

Exclusion criteria

* The stoma was initially recognized as permanent stoma; * Patients with distant metastasis; * Patients with multi-primary colorectal cancer.

Design outcomes

Primary

MeasureTime frame
1-year non-reversal rate of temporary stoma1 year after ostomy

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026